Israel Englander Enanta Pharmaceuticals Inc Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding ENTA
# of Institutions
106Shares Held
18.7MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$14.6 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$14.5 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$12.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA867KShares$5.95 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $142M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...